Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2009 Sep 8;73(10):754-60.
doi: 10.1212/WNL.0b013e3181b23564. Epub 2009 Jul 8.

Conversion of amyloid positive and negative MCI to AD over 3 years: an 11C-PIB PET study

Affiliations
Comparative Study

Conversion of amyloid positive and negative MCI to AD over 3 years: an 11C-PIB PET study

A Okello et al. Neurology. .

Abstract

Background: Patients with amnestic mild cognitive impairment (MCI) represent an important clinical group as they are at increased risk of developing Alzheimer disease (AD). (11)C-PIB PET is an in vivo marker of brain amyloid load.

Objective: To assess the rates of conversion of MCI to AD during a 3-year follow-up period and to compare levels of amyloid deposition between MCI converters and nonconverters.

Methods: Thirty-one subjects with MCI with baseline (11)C-PIB PET, MRI, and neuropsychometry have been clinically followed up for 1 to 3 years (2.68 +/- 0.6 years). Raised cortical (11)C-PIB binding in subjects with MCI was detected with region of interest analysis and statistical parametric mapping.

Results: Seventeen of 31 (55%) subjects with MCI had increased (11)C-PIB retention at baseline and 14 of these 17 (82%) clinically converted to AD during follow-up. Only one of the 14 PIB-negative MCI cases converted to AD. Of the PIB-positive subjects with MCI, half (47%) converted to AD within 1 year of baseline PIB PET, these faster converters having higher tracer-retention values than slower converters in the anterior cingulate (p = 0.027) and frontal cortex (p = 0.031). Seven of 17 (41%) subjects with MCI with known APOE status were epsilon4 allele carriers, this genotype being associated with faster conversion rates in PIB-positive subjects with MCI (p = 0.035).

Conclusions: PIB-positive subjects with mild cognitive impairment (MCI) are significantly more likely to convert to AD than PIB-negative patients, faster converters having higher PIB retention levels at baseline than slower converters. In vivo detection of amyloid deposition in MCI with PIB PET provides useful prognostic information.

PubMed Disclaimer

Figures

None
Figure 1 Amyloid deposition in mild cognitive impairment (MCI) subgroups Scatter plot showing the distribution of individual Pittsburgh compound B (PIB) retention values in PIB-positive MCI subgroups: fast, slow, and nonconverters compared to controls (top line = Turku control mean; bottom line = London control mean).
None
Figure 2 Statistical parametric mapping analysis: Localization of increased 11C-PIB retention in mild cognitive impairment (MCI) converters Surface rendering is used to illustrate the cortical areas (red-yellow) where 11C-PIB retention is significantly increased in MCI converters compared to MCI nonconverters. (Corrected p value at cluster level <0.001.)
None
Figure 3 Statistical parametric mapping: Comparison of 11C-PIB retention in PIB-positive mild cognitive impairment (MCI) subgroups Sagittal (A) and coronal sections (B and C) illustrating increased 11C-PIB retention in anterior cingulate, frontal, and temporal cortex in the PIB-positive MCI faster converters compared to PIB-positive slower converters and nonconverters. Corrected p value at cluster level <0.001.

Comment in

References

    1. Petersen RC, Parisi JE, Dickson DW, et al. Neuropathologic features of amnestic mild cognitive impairment. Arch Neurol 2006;63:665–672. - PubMed
    1. Mufson EJ, Chen EY, Cochran EJ, et al. Entorhinal cortex beta-amyloid load in individuals with mild cognitive impairment. Exp Neurol 1999;158:469–490. - PubMed
    1. Petersen RC, Doody R, Kurz A, et al. Current concepts in mild cognitive impairment. Arch Neurol 2001;58:1985–1992. - PubMed
    1. Boyle PA, Wilson RS, Aggarwal NT, et al. Mild cognitive impairment: risk of Alzheimer disease and rate of cognitive decline. Neurology 2006;67:441–445. - PubMed
    1. Tierney MC, Szalai JP, Snow WG, et al. Prediction of probable Alzheimer’s disease in memory-impaired patients: a prospective longitudinal study. Neurology 1996;46:661–665. - PubMed

Publication types

MeSH terms

Substances